Beyond the scalpel - mortality after liver surgery in patients with liver metastases - time to rethink the indications

Affiliations

¹ Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
² Tagestherapiezentrum, Interdisziplinäres Tumorzentrum, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
³ Department of Radiation Oncology, University Medical Center Freiburg, Freiburg in Breisgau, Magdeburg, Germany.
⁴ Department for Radiation Oncology, University Medical Center Magdeburg, Magdeburg, Germany.
⁵ Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.

Comment

J Boda-Heggemann et al. Br J Surg. 2020 Jan.

. 2020 Jan;107(1):149.

doi: 10.1002/bjs.11412.

¹ Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
² Tagestherapiezentrum, Interdisziplinäres Tumorzentrum, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
³ Department of Radiation Oncology, University Medical Center Freiburg, Freiburg in Breisgau, Magdeburg, Germany.
⁴ Department for Radiation Oncology, University Medical Center Magdeburg, Magdeburg, Germany.
⁵ Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.

No abstract available

Comment in

Mortality after liver surgery in Germany.
Filmann N, Walter D, Schadde E, Bruns C, Keck T, Lang H, Oldhafer K, Schlitt HJ, Schön MR, Herrmann E, Bechstein WO, Schnitzbauer AA. Filmann N, et al. Br J Surg. 2019 Oct;106(11):1523-1529. doi: 10.1002/bjs.11236. Epub 2019 Jul 24. Br J Surg. 2019. PMID: 31339558

1. Filmann N, Walter D, Schadde E, Bruns C, Keck T, Lang H et al. Mortality after liver surgery in Germany. Br J Surg 2019; 106: 1523-1529.
1. Caballero C, Burock S, Carrion-Alvarez L, Nilsson H, Ruers T, Senellart P et al. Building a collaboration to improve surgical research through EORTC/ESSO 1409-CLIMB study: a prospective liver metastasis database with an integrated quality assurance program. Eur J Surg Oncol 2019; 45: 1870-1875.
1. Schnitzbauer AA, Schadde E, Linecker M, Machado MA, Adam R, Malago M et al. Indicating ALPPS for colorectal liver metastases: a critical analysis of patients in the International ALPPS Registry. Surgery 2018; 164: 387-394.
1. Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet 2019; 393: 2051-2058.
1. Gill S, Liu DM, Green HM, Sharma RA. Beyond the knife: the evolving nonsurgical management of oligometastatic colorectal cancer. Am Soc Clin Oncol Educ Book 2018; (38): 209-219.